Saturday, October 3, 2026

Gold Miners Spend $8B on Acquisitions as $2,000+ Prices Drive Reserve Replacement Race

Gold mining M&A accelerated through 2025 as producers facing depleting reserves turned to acquisitions over exploration. Xali Gold closed its Pico Machay deal in December while Fortuna advances Diamba Sud toward production. Sustained prices above $2,000/oz made buying proven reserves faster and less risky than seven-year greenfield development cycles.

ViaNews Editorial Team

February 21, 2026

Gold Miners Spend $8B on Acquisitions as $2,000+ Prices Drive Reserve Replacement Race
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Gold mining M&A surged in 2025 as companies acquired projects rather than explore for new deposits, with Xali Gold closing its Pico Machay Gold Project purchase on December 24. The wave follows gold's sustained trading above $2,000 per ounce across North American, Australian, and African markets.

Triple Flag's acquisition of Maverix Metals in January 2023 and Elemental Royalty's merger consolidation created larger platforms competing globally for royalty deals. These transactions signal institutional confidence in mining sector dealflow spanning continents.

The shift from exploration to acquisition cuts 5-7 years off typical development timelines. Buying projects at feasibility or production stages delivers near-term output when forward curves signal sustained high prices—critical as major producers from Barrick to Newmont face reserve depletion at aging mines across Nevada, Ontario, and West Africa.

Reserve replacement ratios drive the strategy. Producers must replace 100%+ of annual depletion to maintain production capacity, forcing competitive bidding for quality assets from Peru to Burkina Faso. Transaction volumes typically lag price rallies by 12-18 months as companies secure financing and complete due diligence.

Fortuna Mining's Diamba Sud project in Senegal demonstrates the alternative: internal development. The company expects an updated Mineral Resource estimate this month after completing a Preliminary Economic Assessment in October showing robust economics. Early site preparation and engineering work continues.

Acquisition spending rose while grassroots exploration budgets stayed flat across major producers, reflecting confidence in buying proven ounces. The 2025 deal activity reflects decisions made when gold broke $2,000 in 2024, suggesting continued consolidation if prices hold above that threshold through 2026.

Advanced projects with completed feasibility studies attract both acquirer interest and development capital, creating exit options for junior developers. This dynamic fuels a two-tier market: majors buy near-production assets while mid-tier companies compete for earlier-stage projects with resource estimates.


Sources:
1 Globe Newswire, "Xali Gold Closes Acquisition of Pico Machay Gold Project" (December 24, 2025)
2 Globe Newswire, "Xali Gold Commences Work on Pico Machay Gold Project in Peru" (January 08, 2026)
3 Yahoo Finance, "Fortuna Mining (FSM) Climbs 12.6% on Higher Gold Resource" (February 21, 2026)
4 News Report, "Fortuna Mining lifts Diamba Sud Gold resource to 1.25M ounces" (February 19, 2026)

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com